Drug Shortages are Impacting Patient Care, Pharmacy Resources
Drug Topics
NOVEMBER 15, 2024
A conversation with Michael Ganio, PharmD, BCPS, FASHP, senior director of Pharmacy Practice and Quality at ASHP.
Fri.Nov 15, 2024
502 
Can you drink on Zepbound?
The Checkup by Singlecare
NOVEMBER 15, 2024
No matter the time of year, there’s always a family get-together, wedding celebration, or festive party just waiting to sabotage your weight loss goals—with delicious treats and alcoholic beverages. If you’re taking Zepbound (tirzepatide), there’s an added layer to consider besides the extra calories: Is it safe to drink while taking this medication?
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Q&A: Common Reasons Independent Pharmacies Face PBM Audits
Drug Topics
NOVEMBER 15, 2024
A conversation with Trent Thiede, PharmD, MBA, president of PAAS National, at NCPA 2024.
Pay Per Click Essentials for Pharma Marketing Executives: A Beginner’s Guide
Pharma Marketing Network
NOVEMBER 15, 2024
In today’s digital-first world, Pay Per Click (PPC) advertising has become an essential strategy for pharma marketing executives. Imagine having a tool that allows you to target specific audiences actively searching for healthcare solutions, like branded medications or treatment options. PPC does just that. But how does it work, and how can you make the most of it in the competitive pharmaceutical industry?
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Community Pharmacists Crucial in RSV Vaccine Education Efforts
Drug Topics
NOVEMBER 15, 2024
After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.
After US plant reveal, France's Orano Med lays out €250M to build another radioligand facility overseas
Fierce Pharma
NOVEMBER 15, 2024
With multiple drugmakers already announcing a slew of radiopharmaceutical moves this year, France’s Orano Med is doubling down on the nuclear medicine craze. | Orano Med—developing targeted alpha therapies for cancer—kicked off construction of a 250 million euro plant in the Bessines-sur-Gartempe commune of France. Dubbed the Advanced Thorium Extraction Facility, the new 7,000-square-meter site is slated to manufacture thorium-228, a precursor of lead-212, for radioligand therapies.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
The Pharmacy Model Is Changing
Pharmacy Times
NOVEMBER 15, 2024
Embracing artificial intelligence and other tools will be necessary to push the field forward.
Mastering Digital Advertising for Pharma: Strategies That Drive Results
Pharma Marketing Network
NOVEMBER 15, 2024
The digital landscape has transformed how pharmaceutical brands reach healthcare professionals (HCPs) and patients. Digital advertising is no longer just a nice addition; it’s a must-have for every successful pharma marketing strategy. But how do you make your campaigns stand out in such a highly regulated and competitive industry? Let’s explore some proven strategies that will help you master digital advertising and drive significant results.
Where are they now? 4 biotechs that soared then crashed during the pandemic
PharmaVoice
NOVEMBER 15, 2024
How Novavax and others have restructured and trudged forward after their COVID-era high.
Insights on Innovation: Craig Beavers Previews AHA 2024 and Emerging Trends in Cardiovascular Care
Pharmacy Times
NOVEMBER 15, 2024
Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, CACP will be moderating a session about social determinants of health and heart failure.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
What is enalapril used for in dogs?
The Checkup by Singlecare
NOVEMBER 15, 2024
Enalapril is one of the most commonly used prescription medications to treat canine congestive heart failure , kidney disease, or high blood pressure. All are serious, chronic, and progressive conditions. Enalapril treatment improves the dog’s health, slows the progress of these diseases, and lengthens the dog’s life. RELATED: Save up to 80% on enalapril What is enalapril used for in dogs?
FDA Approves Revumenib for the Treatment of Relapsed or Refractory Acute Leukemia
Pharmacy Times
NOVEMBER 15, 2024
The indication is for adult and pediatric patients 1 year and older with a lysine methyltransferase 2A gene translocation.
Tips to strengthen clinical trials by improving the patient experience
pharmaphorum
NOVEMBER 15, 2024
Explore valuable tips and strategies to enhance clinical trials by prioritising and improving the overall patient experience. Learn how to optimise patient recruitment, retention, and satisfaction through effective communication and personalised support.
Shingles Vaccine Could Protect Cardiovascular Health
Pharmacy Times
NOVEMBER 15, 2024
Pharmacists can continue to spread awareness of the importance of receiving a shingles vaccine.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
EMA’s CHMP recommends Sanofi’s Sarclisa approval for multiple myeloma
Pharmaceutical Technology
NOVEMBER 15, 2024
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Sanofi’s Sarclisa combined with Velcade, plus Revlimid, plus dexamethasone (VRd) for treating newly diagnosed multiple myeloma (MM).
Intravenous Immunoglobulin Elicits Favorable Response in Pregnant Patient With Pemphigoid Gestationis
Pharmacy Times
NOVEMBER 15, 2024
IVIG was found to cease development of new lesions and heal previously documented erosions without adverse events to the patient or fetus.
Virtual maternal health startup Ruth Health shutters, CEO announces
Fierce Healthcare
NOVEMBER 15, 2024
Ruth Health, a tech-enabled maternal health startup founded in 2020, is shuttering. | The startup, intended to be an extension of a patient’s existing care team, offered a suite of remote patient services, including doula care, pelvic floor training, lactation counseling, C-section recovery resources and intimacy and sexual support for new moms.
Half of Pharmacy Technicians Feel Fulfilled in Their Current Role
Pharmacy Times
NOVEMBER 15, 2024
The Connecticut Society of Health-System Pharmacists Technician Committee survey explores the perception of career growth opportunities and challenges.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA nod for Azurity's Danziten will allow patients to take leukemia med without fasting
Fierce Pharma
NOVEMBER 15, 2024
Azurity Pharmaceuticals has earned an FDA approval for Danziten, a new formulation of Novartis’ chronic myeloid leukemia (CML) blockbuster Tasigna.
FDA Grants New Nilotinib Formulation Approval to Treat Adults With Chronic Myeloid Leukemia
Pharmacy Times
NOVEMBER 15, 2024
The tablets become the first and only nilotinib with no mealtime restrictions indicated for this population.
Genesis Therapeutics expands AI drug discovery collaboration with $200M funding
Outsourcing Pharma
NOVEMBER 15, 2024
Genesis Therapeutics has secured $200 million funding from NVentures, NVIDIAâs venture capital arm.
AHA 2024: High Temperatures Linked to Irregular Heartbeat in Individuals With Implanted Defibrillators
Pharmacy Times
NOVEMBER 15, 2024
The global temperature has risen by an average of 0.11° Fahrenheit per decade since 1850, or about 2 degrees in total.
Lecanemab Gets Nod from CHMP for Use in Early Alzheimer’s Disease
BioPharm
NOVEMBER 15, 2024
Eisai Europe and Biogen have received a positive opinion for the monoclonal antibody therapy to be used as a treatment of adult patients with early Alzheimer’s disease.
FDA Accepts sBLA Review for Dupilumab in Treatment of CSU in Adult and Pediatric Patients
Pharmacy Times
NOVEMBER 15, 2024
The indication is for patients 12 and older with chronic spontaneous urticaria (CSU) whose disease is not adequately controlled with H1 antihistamine treatment.
3 Ways AI Can Enable Health Systems to Achieve the Quadruple Aim
Fierce Healthcare
NOVEMBER 15, 2024
By: Dave Henriksen | Explore three ways AI can help health systems achieve the Quadruple Aim, with insights and examples from real healthcare organizations.
Optimizing Self-Management for Outpatient Pharmacy Patients With Diabetes
Pharmacy Times
NOVEMBER 15, 2024
The use of outpatient pharmacy protocols for glucose testing and insulin administration supplies should be expanded to assist patients in the self-management of diabetes.
Chutes & Ladders—Centene president to retire, Abridge and AccessHope tap industry execs
Fierce Healthcare
NOVEMBER 15, 2024
Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. | Welcome to this week's Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please submit the good news—or the bad—from your shop, and we will feature it here at the end of each week.
AHA 2024: AI Tool Could Provide Fast, No-Contact Blood Pressure and Diabetes Screenings
Pharmacy Times
NOVEMBER 15, 2024
The system, currently in early development in Japan, could minimize the need for blood tests, blood pressure cuffs, or expensive wearable devices.
Melatonin Uses and Benefits
Compounding Pharmacy of America
NOVEMBER 15, 2024
Melatonin is a natural hormone produced by our bodies. When taken as a supplement, the hormone can deliver important health benefits, like sleep support. The post Melatonin Uses and Benefits appeared first on The Compounding Pharmacy of America.
Frontier Scientific Solutions to use $1.5 Billion Funds to Establish Global Free Trade Zone Gateway for Life Sciences Supply Chain
BioPharm
NOVEMBER 15, 2024
Empowered by a $1.5 billion commitment from a major investor, Frontier Scientific Solutions has unveiled its plans for establishing a global free trade zone gateway intended for facilitating the life sciences supply chain using Wilmington International Airport in North Carolina.
Noam Solomon: Bringing the Human Story to AI
PharmExec
NOVEMBER 15, 2024
A look at one biotech’s mission to map the immune system using artificial intelligence—and how its growth as a Big Pharma partner could help unlock the potential of next-generation cancer treatments.
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
Pharmaceutical Technology
NOVEMBER 15, 2024
The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.
AI’s Attention Span
PharmExec
NOVEMBER 15, 2024
Developments in the world of artificial intelligence continue to accelerate at a rapid pace. Our November issue of Pharmaceutical Executive explores a few of those that are starting to deliver measurable gains for the industry.
Let's personalize your content